Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases pp 227-230 | Cite as
Enzymological Aspects of the Actions of the Parkinsonism-Inducing Neurotoxin MPTP
Abstract
The role of the B-form of monoamine oxidase (MAO-B) in converting the compound MPTP (1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine) to neurotoxic metabolites is well-established from studies on the protection afforded by selective inhibitors of that enzyme (for reviews see Singer et al., 1987; Kinemuchi et al., 1987). The neurotoxic metabolite appears to be the 4-electron oxidation product, the 4-phenylpyridinium ion (MPP(+)). It has been proposed that the action of this compound as an inhibitor of mitochondrial oxidative phosphorylation from NADH may account for its neurotoxicity (Nicklas et al., 1985; Ramsay et al., 1986).
Keywords
Monoamine Oxidase Brain Mitochondrion Mitochondrial Oxidative Phosphorylation Partition Ratio Deuterium Isotope EffectPreview
Unable to display preview. Download preview PDF.
References
- Corongiu, F.P., Dessi, M.A., Banni, S., Bernardi, F., Piccardi, M.P. Del Zompo, M. and Corsini, G.U., 1987, MPTP fails to induce lipid peroxidation in vivo, Biochem. Pharmacol., 36: 2551.CrossRefGoogle Scholar
- Fowler, C.J. and Strolin Benedetti, M., 1983, The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by címoxatone, J. Neurochem. 40: 1534.PubMedCrossRefGoogle Scholar
- Fowler, C.J., Wiberg, A., Oreland, L., Marcusson, J. and Winblad, B., 1980, The effects of age on the activity and molecular properties of human brain monoamine oxidase, J. Neural Transm. 49: 1.PubMedCrossRefGoogle Scholar
- Gotz, M.E., Freyberger, A. and Riederer, P., 1989, Oxidative stress: a role in the pathogenesis of Parkinson’s disease, J. Neural Transm., in press.Google Scholar
- Irwin, I.J., Langston, W.L. and Delanney, L.E., 1987, 5-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP(+) concentration and neurotoxicity, Life Sci, 40: 731.CrossRefGoogle Scholar
- Jenner, P. and Marsden, C.D., 1986, The actions of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine in animals as models of Parkinson’s disease, J. Neural Transm., suppl. 20: 11.Google Scholar
- Kinemuchi, H., Fowler, C.J. and Tipton, K.F., 1987, The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its relevance to Parkinson’s disease, Neurochem. Int., 11: 359.PubMedCrossRefGoogle Scholar
- Nicklas, W.J., Vyas, I. and Heikkila, R.E., 1985, Inhibition of NAD-linked oxidation in human brain mitochondria by 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine, Life Sci, 36: 2503.PubMedCrossRefGoogle Scholar
- O’Carroll, A.-M., Tipton„ K.F., Sullivan, J.P., Fowler, C.J. and Ross, S.B., 1987, Intra-and extra-synaptosomal deamination of dopamine and noradrenaline by the two forms of human brain monoamine oxidase, implications for the neurotoxicity of N-methyl-4-phenyl-1,2,3,6tetrahydropyridine in man, Biogenic Aamines, 4: 165.Google Scholar
- Ottoboni, S., Caldera, P., Trevor, A. and Castagnoli, N., 1989, Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B, J. Biol. Chem., 264: 13684.PubMedGoogle Scholar
- Ramsay, R.R., Dadgar, J.I., Trevor, A. and Singer, T.P., 1986, Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity, Life Sci, 39: 581.PubMedCrossRefGoogle Scholar
- Salachi, J.I., 1979, Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties and determination of its cysteinyl flavin content, Arch. Biochem. Biophys, 192: 128.CrossRefGoogle Scholar
- Singer, T.P., Castagnoli, N., Ramsay, R.R. and Trevor, A.J., 1987, Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Neurochem., 49: 1.PubMedCrossRefGoogle Scholar
- Snyder, S.H. and D’Amato, R.J., 1985, Predicting Parkinson’s disease, Nature, 317: 198.PubMedCrossRefGoogle Scholar
- Sullivan, J.P. and Tipton, K.F., 1988, Interactions of monoamine oxidase and MPTP in human brain, In “Neurotoxins in Neurochemistry”, J.0. Dolly, ed, Ellis Horwood, Chichester, p. 125.Google Scholar
- Thorpe, L.W., Westlund, K.N., Kochersperger, L.M., Abell, C.W. and Denney, R.M., 1987, Immunocytochemical localisation of monoamine oxidase A and B in human peripheral tissue and brain, J. Histochem. Cytochem., 35: 23.PubMedCrossRefGoogle Scholar
- Tipton, K.F., McCrodden, J.M. and Youdim, M.B.H., 1986, Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Biochem. J., 125–521.Google Scholar
- Tipton, K.F. and Sullivan, J.P., 1989, Biochemical aspects of the neuro-toxicity of 1-methy1–4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Roy. Irish Acad., in press.Google Scholar
- Trevor, A.J., Chiba, K., Yu, E.Y., Caldera, P.S., Castagnoli, K.P., Castagboli, N., Peterson, L., Salach, J.I. and Singer, T.P., 1986, in: “MPTP: A neurotoxin producing a parkinsonian syndrome”, S.P. Markey, N. Castagnoli, A.J. Trevor and I.K. Kopin, eds., Academic Press, New York, p. 161.Google Scholar